An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma

By Reichardt Peter   Oechsle Karin   Pink Daniel   Bokemeyer Carsten   Schneller F.   Issels Rolf   Kanz Lothar   Hartmann Jörg Thomas  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 481-486

Springer Publishing Company

Access to resources Recommend Favorite

Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone

By Paz-Ares Luis  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 729-740

Springer Publishing Company

Access to resources Recommend Favorite

A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas

By Hartmann Jörg   Horger M.   Kluba T.   Königsrainer A.   Zwart P.   Weyhern C.   Eckert F.   Budach W.   Bokemeyer C.  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1592-1601

Springer Publishing Company

Access to resources Recommend Favorite

Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer: An Open-Label, Non-Comparative, Multicentre, Phase III Study

By Lundström Eija A.  

Clinical Drug Investigation, Vol. 29, Iss. 12, 2009-12 ,pp. : 757-765

Adis International

Access to resources Recommend Favorite

Manidipine for Hypertension not Controlled by Dual Therapy in Patients with Diabetes Mellitus: A Non-Comparative, Open-Label Study

By Martell-Claros Nieves  

Clinical Drug Investigation, Vol. 31, Iss. 6, 2011-06 ,pp. : 427-434

Adis International

Access to resources Recommend Favorite